The Effect of Mild or Moderate Hepatic Impairment (Cirrhosis) on the Pharmacokinetics of Zileuton
- 1 January 1995
- journal article
- research article
- Published by Springer Nature in Clinical Pharmacokinetics
- Vol. 29 (2) , 49-61
- https://doi.org/10.2165/00003088-199500292-00008
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- The Pharmacokinetics of Zileuton in Healthy Young and Elderly VolunteersClinical Pharmacokinetics, 1995
- Determination of a New 5-Lipoxygenase Inhibitor, Zileuton, and its Inactive N-Dehydroxylated Metabolite in Plasma by High Performance Liquid ChromatographyClinical Pharmacokinetics, 1995
- Glucuronidation of zileuton (A-64077) by human hepatic microsomes.1992
- Phase II study of the safety and efficacy of a 5-lipoxygenase inhibitor in patients with ulcerative colitis.1992
- 1 5-Lipoxygenase Inhibitors and their Anti-inflammatory ActivitiesProgress in Medicinal Chemistry, 1992
- Effect of Zileuton (A-64077) on the 5-lipoxygenase activity of human whole bloodex vivoInflammation Research, 1991
- 5-lipoxygenase inhibitory activity of zileuton.1991
- Reduced Allergen-Induced Nasal Congestion and Leukotriene Synthesis with an Orally Active 5-Lipoxygenase InhibitorNew England Journal of Medicine, 1990
- The Effects of a 5-Lipoxygenase Inhibitor on Asthma Induced by Cold, Dry AirNew England Journal of Medicine, 1990
- Superiority of the Child-Pugh Classification to Quantitative Liver Function Tests for Assessing Prognosis of Liver CirrhosisScandinavian Journal of Gastroenterology, 1989